Latest News
|
More Articles...
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Adagio Medical Treats First Persistent Atrial Fibrillation Patient with One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging
- Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias
- BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III
- Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation
- CardioFocus Announces Impressive Results from Pivotal Confirmatory Study with The Breakthrough HeartLight® X3 System
- Late-Breaking Trial Data Highlight Continued Clinical Success of Boston Scientific EMBLEM™ S-ICD System
- CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device
|
|
